🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This study is a randomized, double-blind and placebo-controlled trial with ...
Status
Completed
Location
Peking University People's Hospital
Start Date
2015-05
Trial ID
NCT02460393
Treatments Being Tested
The purpose of this study is to compare the safety and efficacy of secukinu...
Status
Completed
Location
Novartis Investigative Site
Start Date
2020-12-21
Trial ID
NCT04632927
Treatments Being Tested
The aim of the study will be to investigate the effect of certolizumab pego...
Status
Completed
Location
Multiple Locations
Start Date
2006-02
Trial ID
NCT00297648
Treatments Being Tested
The underlying hypothesis is that vedolizumab will modify immune cell traff...
Status
Completed
Location
University of California San Diego
Start Date
2022-09-21
Trial ID
NCT05281614
Treatments Being Tested
The purpose of the study is to assess the safety and efficacy of adalimumab...
Status
Completed
Location
Site Reference ID/Investigator# 322
Start Date
2000-12
Trial ID
NCT00195663
Treatments Being Tested
RABIOPRED is an in vitro non-invasive blood test, which aims to identify pa...
Status
Terminated
Location
Institute of Rheumatology
Start Date
2016-12
Trial ID
NCT03016260
The purpose of this study is to assess the efficacy of ustekinumab, in adul...
Status
Terminated
Location
Multiple Locations
Start Date
2015-09-03
Trial ID
NCT02437162
Treatments Being Tested
The primary objective of this study is to evaluate the efficacy of atacicep...
Status
Completed
Location
Please Contact US Medical Information
Start Date
2007-09
Trial ID
NCT00595413
Treatments Being Tested
This study will continue to evaluate the safety \& efficacy of Certolizumab...
Status
Completed
Location
037
Start Date
2014-11
Trial ID
NCT02319642
Treatments Being Tested
Preliminary data suggest that up-regulation of Interleukin -17 (IL-17) and ...
Status
Completed
Location
Cambridge University Hospitals NHS Foundation Trust, Addenbrooke's Hospital
Start Date
2015-03
Trial ID
NCT02620189
Treatments Being Tested